Coherus Announces Resubmission of Biologics License Application (BLA) Supplement for UDENYCA® ONBODY™
– Resubmission follows the satisfactory resolution of the FDA’s review of inspection findings at the third-party filler – REDWOOD CITY, Calif.,...
– Resubmission follows the satisfactory resolution of the FDA’s review of inspection findings at the third-party filler – REDWOOD CITY, Calif.,...
TN-201 is the First Gene Therapy for the Leading Genetic Cause of HCM to be Assessed in Humans; Adds Working...
BMF-219 is a novel covalent menin inhibitor designed to regenerate insulin-producing beta cells with the aim to cure type 1...
CLEVELAND, OH / ACCESSWIRE / October 4, 2023 / MediOrbis, a global multi-specialty telehealth company with comprehensive specialty telemedicine services...
Fiscal Year 2024 First Quarter Highlights Net sales of $78.7 million as reported Includes $0.7 million of Dialysis and BioSentry...
Portland, Oregon--(Newsfile Corp. - October 4, 2023) - FloraWorks Holdings Inc., a leading cannabinoid therapeutics company, announced the appointment of Dr....
TORONTO, ON / ACCESSWIRE / October 4, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
mRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity and safety profile, compared to licensed standalone vaccinesCompany...
- Continued Progress in the Global Development and Commercialization of XIPERE® (known as ARCATUS® in China) - ALPHARETTA, Ga., Oct....
PHILADELPHIA, Pa. and VANCOUVER, British Columbia, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT)...
KELOWNA, BC / ACCESSWIRE / October 4, 2023 / Tryp Therapeutics Inc. ("Tryp" or the "Company") (CSE:TRYP) announces that, further...
Calgary, Alberta--(Newsfile Corp. - October 3, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce...
GALWAY, Ireland--(BUSINESS WIRE)--Loci Orthopaedics announced today that it has successfully completed enrolment of a 15-patient clinical feasibility study for its...
Elevating Global Patient Access to Clinical Trials through Revolutionary Collaboration and Advanced AI-Driven TechnologiesNEW YORK--(BUSINESS WIRE)--Massive Bio Inc., a trailblazing...
THANC Guide resource center for thyroid, head and neck cancer patients will now feature Carebox Connect for clinical trial search...
Figure 2: Systolic Blood Pressure (SBP) Mean change from baseline in SBP vs time. (A) Single dose. (B) Repeat dose....
PALO ALTO, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
Radicle Science studied MDSleep in one of history’s largest clinical trials on a supplement brand’s sleep formulation.Los Angeles, CA, Oct....
Expands access to vertebrogenic pain treatment for 36 million patientsMINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company...
Cannabix Technologies Inc. Cannabix Technologies MSBS and BCU Figures 1 and 2 VANCOUVER, British Columbia, Oct. 03, 2023 (GLOBE NEWSWIRE)...